191 related articles for article (PubMed ID: 33004948)
1. Lactobacillus reuteri DSM 17938 and ATCC PTA 5289 ameliorates chemotherapy-induced oral mucositis.
Gupta N; Ferreira J; Hong CHL; Tan KS
Sci Rep; 2020 Oct; 10(1):16189. PubMed ID: 33004948
[TBL] [Abstract][Full Text] [Related]
2. In silico, in vitro and in vivo safety evaluation of Limosilactobacillus reuteri strains ATCC PTA-126787 & ATCC PTA-126788 for potential probiotic applications.
Gangaiah D; Mane SP; Tawari NR; Lakshmanan N; Ryan V; Volland A; Susanti D; Patel M; Abouzeid A; Helmes EB; Kumar A
PLoS One; 2022; 17(1):e0262663. PubMed ID: 35081129
[TBL] [Abstract][Full Text] [Related]
3. Modulations of probiotics on gut microbiota in a 5-fluorouracil-induced mouse model of mucositis.
Yeung CY; Chiang Chiau JS; Cheng ML; Chan WT; Chang SW; Chang YH; Jiang CB; Lee HC
J Gastroenterol Hepatol; 2020 May; 35(5):806-814. PubMed ID: 31674687
[TBL] [Abstract][Full Text] [Related]
4. SCID/NOD mice model for 5-FU induced intestinal mucositis: Safety and effects of probiotics as therapy.
Huang L; Chiang Chiau JS; Cheng ML; Chan WT; Jiang CB; Chang SW; Yeung CY; Lee HC
Pediatr Neonatol; 2019 Jun; 60(3):252-260. PubMed ID: 30150027
[TBL] [Abstract][Full Text] [Related]
5. Regulatory role of Lactobacillus acidophilus on inflammation and gastric dysmotility in intestinal mucositis induced by 5-fluorouracil in mice.
Justino PF; Melo LF; Nogueira AF; Morais CM; Mendes WO; Franco AX; Souza EP; Ribeiro RA; Souza MH; Soares PM
Cancer Chemother Pharmacol; 2015 Mar; 75(3):559-67. PubMed ID: 25572363
[TBL] [Abstract][Full Text] [Related]
6.
Maya-Barrios A; Lira-Hernandez K; Jiménez-Escobar I; Hernández L; Ortiz-Hernandez A; Jiménez-Gutiérrez C; López-Velázquez G; Gutiérrez-Castrellón P
Benef Microbes; 2021 Apr; 12(2):137-145. PubMed ID: 33789556
[TBL] [Abstract][Full Text] [Related]
7. Human-derived probiotic Lactobacillus reuteri strains differentially reduce intestinal inflammation.
Liu Y; Fatheree NY; Mangalat N; Rhoads JM
Am J Physiol Gastrointest Liver Physiol; 2010 Nov; 299(5):G1087-96. PubMed ID: 20798357
[TBL] [Abstract][Full Text] [Related]
8. Effect of atorvastatin on 5-fluorouracil-induced experimental oral mucositis.
Medeiros CA; Leitão RF; Macedo RN; Barboza DR; Gomes AS; Nogueira NA; Alencar NM; Ribeiro RA; Brito GA
Cancer Chemother Pharmacol; 2011 May; 67(5):1085-100. PubMed ID: 20661736
[TBL] [Abstract][Full Text] [Related]
9.
Liu Y; Tian X; He B; Hoang TK; Taylor CM; Blanchard E; Freeborn J; Park S; Luo M; Couturier J; Tran DQ; Roos S; Wu G; Rhoads JM
Am J Physiol Gastrointest Liver Physiol; 2019 Dec; 317(6):G824-G838. PubMed ID: 31482733
[TBL] [Abstract][Full Text] [Related]
10. Protective effect of Bu-Zhong-Yi-Qi decoction, the water extract of Chinese traditional herbal medicine, on 5-fluorouracil-induced intestinal mucositis in mice.
Gou H; Gu LY; Shang BZ; Xiong Y; Wang C
Hum Exp Toxicol; 2016 Dec; 35(12):1243-1251. PubMed ID: 26801985
[TBL] [Abstract][Full Text] [Related]
11. Genome-scale insights into the metabolic versatility of Limosilactobacillus reuteri.
Luo H; Li P; Wang H; Roos S; Ji B; Nielsen J
BMC Biotechnol; 2021 Jul; 21(1):46. PubMed ID: 34330235
[TBL] [Abstract][Full Text] [Related]
12. Amelioration of Chemotherapy-Induced Intestinal Mucositis by Orally Administered Probiotics in a Mouse Model.
Yeung CY; Chan WT; Jiang CB; Cheng ML; Liu CY; Chang SW; Chiang Chiau JS; Lee HC
PLoS One; 2015; 10(9):e0138746. PubMed ID: 26406888
[TBL] [Abstract][Full Text] [Related]
13. Lactobacillus reuteri prevents diet-induced obesity, but not atherosclerosis, in a strain dependent fashion in Apoe-/- mice.
Fåk F; Bäckhed F
PLoS One; 2012; 7(10):e46837. PubMed ID: 23056479
[TBL] [Abstract][Full Text] [Related]
14. Genomic, phenotypic, and clinical safety of Limosilactobacillus reuteri ATCC PTA 4659.
Sendelius M; Axelsson J; Liu P; Roos S
J Ind Microbiol Biotechnol; 2023 Feb; 50(1):. PubMed ID: 37974056
[TBL] [Abstract][Full Text] [Related]
15. Protective effect of Lactobacillus reuteri DSM 17938 against experimental necrotizing enterocolitis is mediated by Toll-like receptor 2.
Hoang TK; He B; Wang T; Tran DQ; Rhoads JM; Liu Y
Am J Physiol Gastrointest Liver Physiol; 2018 Aug; 315(2):G231-G240. PubMed ID: 29648878
[TBL] [Abstract][Full Text] [Related]
16. Puerarin Ameliorates 5-Fluorouracil-Induced Intestinal Mucositis in Mice by Inhibiting JAKs.
Wang L; Song B; Hu Y; Chen J; Zhang S; Chen D; Wang J
J Pharmacol Exp Ther; 2021 Nov; 379(2):147-155. PubMed ID: 34400527
[TBL] [Abstract][Full Text] [Related]
17. Oral Microbiota Shift after 12-Week Supplementation with Lactobacillus reuteri DSM 17938 and PTA 5289; A Randomized Control Trial.
Romani Vestman N; Chen T; Lif Holgerson P; Öhman C; Johansson I
PLoS One; 2015; 10(5):e0125812. PubMed ID: 25946126
[TBL] [Abstract][Full Text] [Related]
18. Oral colonization by Lactobacillus reuteri ATCC 55730 after exposure to probiotics.
Caglar E; Topcuoglu N; Cildir SK; Sandalli N; Kulekci G
Int J Paediatr Dent; 2009 Sep; 19(5):377-81. PubMed ID: 19486373
[TBL] [Abstract][Full Text] [Related]
19. Amifostine reduces inflammation and protects against 5-fluorouracil-induced oral mucositis and hyposalivation.
Barbosa SCM; Pereira VBM; Wong DVT; Santana APM; Lucetti LT; Carvalho LL; Barbosa CRN; Callado RB; Silva CAA; Lopes CDH; Brito GAC; Alencar NMN; Lima-Júnior RCP
Braz J Med Biol Res; 2019 Feb; 52(3):e8251. PubMed ID: 30810625
[TBL] [Abstract][Full Text] [Related]
20. Anti-inflammatory effect of L-cysteine (a semi-essential amino acid) on 5-FU-induced oral mucositis in hamsters.
Fonseca KM; Macda RodriguesCosta D; da Silva VF; de Carvalho JL; Oliveira AP; de Melo Sousa FB; Lopes ALF; da Silva Martins C; de Sousa Chaves L; Nicolau LAD; Cerqueira GS; Medeiros JVR
Amino Acids; 2021 Sep; 53(9):1415-1430. PubMed ID: 34410507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
